In the fight against cancer, immunotherapy—which aims to boost the body's natural defenses against cancer—is experiencing ...

In the fight against cancer, immunotherapy - which aims to boost the body's natural defences against cancer - is experiencing remarkable growth. Most of these treatments are based on CD8 T lymphocytes ...

Women aged 65 and above are still at heightened risk of cervical cancer caused by human papillomavirus (HPV), suggest the ...

A Bermudian played a key role in groundbreaking research that led to the understanding of how a devastating cancer can spread ...

The QUILT-88 study reveals promising survival rates for advanced pancreatic cancer patients using a multimodal treatment ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...

June brought genitourinary cancer updates, and CURE is sharing the latest in kidney cancer treatment, as well as FDA ...

New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...

A map showing the development of somatic cell mutations in the human body has been released. A research team led by Professor ...

Researchers found that clinically achievable doses of curcumin, the active compound in turmeric, target and suppress ...

Data from the DeLLphi-304 trial “clearly support tarlatamab as a preferable therapy” for SCLC in the second-line setting, said Charles M. Rudin, MD, PhD.